|

Arthritis Clinical Trials in Maryland

37 recruiting studies across 1 city

Browse by City

Baltimore
37 trials

All Trials in Maryland

Phase
Trial Phase Dist.
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisPhase 2<1 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1<1 mi
The Myelin Disorders Biorepository Project—<1 mi
RA-PRO PRAGMATIC TRIALPhase 3<1 mi
Innovations in Genicular Outcomes Registry—<1 mi
The Pericapsular Nerve Block in Total Hip ArthroplastyPhase 4<1 mi
Sleep TO Prevent Post-surgical PainN/A<1 mi
Safety and Effectiveness of the HIT Reverse HRSN/A<1 mi
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement SystemN/A<1 mi
Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis PainPhase 4<1 mi
Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot Versus Single Radius Design for Total Knee ArthroplastyN/A<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 3<1 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.Phase 3<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 3<1 mi
Primary Subtalar Arthrodesis for Calcaneal FracturesN/A<1 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisPhase 2<1 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)Phase 1<1 mi
Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlarePhase 29 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 332 mi
A Study of SPY072 in Rheumatic DiseasePhase 232 mi
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Phase 232 mi
Phase 3 Study of Telitacicept in Active Primary Sjögren's DiseasePhase 332 mi
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study—34 mi
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis—34 mi
Study of Alkaptonuria—34 mi
Natural History and Development of Spondyloarthritis—34 mi
The Pathogenesis and Natural History of Sjogren's Disease—34 mi
Characterization of Diseases With Salivary Gland Involvement—34 mi
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren DiseasePhase 234 mi
Studies of the Natural History of Rheumatic Diseases—34 mi
Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions—34 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabPhase 336 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—36 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.Phase 336 mi
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions—36 mi
Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency DepartmentPhase 447 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPhase 248 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.